Tead and AP1 Coordinate Transcription and Motility

Cell Reports

Volumn 14, Issue 5, 2016, Pages 1169-1180

  Liu, Xiangfan ^a   Li, Huapeng ^a   Rajurkar, Mihir ^a,d   Li, Qi ^a   Cotton, Jennifer L ^a   Ou, Jianhong ^a   Zhu, Lihua J ^a   Goel, Hira L ^a   Mercurio, Arthur M ^a   Park, Joo Seop ^b   Davis, Roger J ^a,c   Mao, Junhao ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AP1; Invasion; Tead; Transcriptional regulation

Indexed keywords

REGULATOR PROTEIN; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TEAD4 PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MUSCLE PROTEIN; PROTEIN BINDING; STRESS ACTIVATED PROTEIN KINASE; TEAD4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIAL CANCER CELL LINE; GENE CONTROL; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER CELL LINE; NEUROBLASTOMA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOLOGICAL MODEL; CELL MOTION; CLUSTER ANALYSIS; GENETIC TRANSCRIPTION; GENETICS; HUMAN GENOME; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; REGULATORY SEQUENCE; TUMOR CELL LINE; TUMOR INVASION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CLUSTER ANALYSIS; DNA-BINDING PROTEINS; GENOME, HUMAN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASMS; PROTEIN BINDING; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84957990196     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.12.104     Document Type: Article

References (49)

1. Belandia B., Parker M.G. Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J. Biol. Chem. 2000, 275:30801-30805.
2. Bradley W.D., Koleske A.J. Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts. J. Cell Sci. 2009, 122:3441-3454.
3. Chang C., Goel H.L., Gao H., Pursell B., Shultz L.D., Greiner D.L., Ingerpuu S., Patarroyo M., Cao S., Lim E., et al. A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cells. Genes Dev. 2015, 29:1-6.
4. Chen Z., Friedrich G.A., Soriano P. Transcriptional enhancer factor 1 disruption by a retroviral gene trap leads to heart defects and embryonic lethality in mice. Genes Dev. 1994, 8:2293-2301.
5. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
6. de Both N.J., Vermey M., Dinjens W.N., Bosman F.T. A comparative evaluation of various invasion assays testing colon carcinoma cell lines. Br. J. Cancer 1999, 81:934-941.
7. Dong J., Feldmann G., Huang J., Wu S., Zhang N., Comerford S.A., Gayyed M.F., Anders R.A., Maitra A., Pan D. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
8. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., Zanconato F., Le Digabel J., Forcato M., Bicciato S., et al. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474:179-183.
9. Gupta M.P., Amin C.S., Gupta M., Hay N., Zak R. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol. Cell. Biol. 1997, 17:3924-3936.
10. Halder G., Camargo F.D. The hippo tumor suppressor network: from organ size control to stem cells and cancer. Cancer Res. 2013, 73:6389-6392.
11. Halder G., Polaczyk P., Kraus M.E., Hudson A., Kim J., Laughon A., Carroll S. The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev. 1998, 12:3900-3909.
12. Halder G., Dupont S., Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 2012, 13:591-600.
13. Hong W., Guan K.L. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. Semin. Cell Dev. Biol. 2012, 23:785-793.
14. Kaneko K.J., DePamphilis M.L. Regulation of gene expression at the beginning of mammalian development and the TEAD family of transcription factors. Dev. Genet. 1998, 22:43-55.
15. Lai D., Ho K.C., Hao Y., Yang X. Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. Cancer Res. 2011, 71:2728-2738.
16. Laurin M., Côté J.F. Insights into the biological functions of Dock family guanine nucleotide exchange factors. Genes Dev. 2014, 28:533-547.
17. Lee K.K., Yonehara S. Identification of mechanism that couples multisite phosphorylation of Yes-associated protein (YAP) with transcriptional coactivation and regulation of apoptosis. J. Biol. Chem. 2012, 287:9568-9578.
18. Lee S.K., Kim H.J., Na S.Y., Kim T.S., Choi H.S., Im S.Y., Lee J.W. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J. Biol. Chem. 1998, 273:16651-16654.
19. Lei Y., Henderson B.R., Emmanuel C., Harnett P.R., deFazio A. Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis. Oncogene 2015, 34:485-495.
20. Louis C.U., Shohet J.M. Neuroblastoma: molecular pathogenesis and therapy. Annu. Rev. Med. 2015, 66:49-63.
21. Meixner A., Karreth F., Kenner L., Penninger J.M., Wagner E.F. Jun and JunD-dependent functions in cell proliferation and stress response. Cell Death Differ. 2010, 17:1409-1419.
22. Moroishi T., Hansen C.G., Guan K.L. The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer 2015, 15:73-79.
23. Nishioka N., Yamamoto S., Kiyonari H., Sato H., Sawada A., Ota M., Nakao K., Sasaki H. Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos. Mech. Dev. 2008, 125:270-283.
24. Pan D. The hippo signaling pathway in development and cancer. Dev. Cell 2010, 19:491-505.
25. Pobbati A.V., Hong W. Emerging roles of TEAD transcription factors and its coactivators in cancers. Cancer Biol. Ther. 2013, 14:390-398.
26. Pobbati A.V., Chan S.W., Lee I., Song H., Hong W. Structural and functional similarity between the Vgll1-TEAD and the YAP-TEAD complexes. Structure 2012, 20:1135-1140.
27. Qian X., Li G., Vass W.C., Papageorge A., Walker R.C., Asnaghi L., Steinbach P.J., Tosato G., Hunter K., Lowy D.R. The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell 2009, 16:246-258.
28. Qin L., Wu Y.L., Toneff M.J., Li D., Liao L., Gao X., Bane F.T., Tien J.C., Xu Y., Feng Z., et al. NCOA1 directly targets M-CSF1 expression to promote breast cancer metastasis. Cancer Res. 2014, 74:3477-3488.
29. Sarkar D., Wang X.Y., Fisher P.B. Targeting JunD: a potential strategy to counteract hormone-refractory prostate cancer. Cell Cycle 2011, 10:3433.
30. Sawada A., Kiyonari H., Ukita K., Nishioka N., Imuta Y., Sasaki H. Redundant roles of Tead1 and Tead2 in notochord development and the regulation of cell proliferation and survival. Mol. Cell. Biol. 2008, 28:3177-3189.
31. Schonthaler H.B., Guinea-Viniegra J., Wagner E.F. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann. Rheum. Dis. 2011, 70(Suppl 1):i109-i112.
32. Shao D.D., Xue W., Krall E.B., Bhutkar A., Piccioni F., Wang X., Schinzel A.C., Sood S., Rosenbluh J., Kim J.W., et al. KRAS and YAP1 converge to regulate EMT and tumor survival. Cell 2014, 158:171-184.
33. Sun G., Irvine K.D. Ajuba family proteins link JNK to Hippo signaling. Sci. Signal. 2013, 6:ra81.
34. Tomlinson V., Gudmundsdottir K., Luong P., Leung K.Y., Knebel A., Basu S. JNK phosphorylates Yes-associated protein (YAP) to regulate apoptosis. Cell Death Dis. 2010, 1:e29.
35. Tsujiura M., Mazack V., Sudol M., Kaspar H.G., Nash J., Carey D.J., Gogoi R. Yes-associated protein (YAP) modulates oncogenic features and radiation sensitivity in endometrial cancer. PLoS ONE 2014, 9:e100974.
36. Verde P., Casalino L., Talotta F., Yaniv M., Weitzman J.B. Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters. Cell Cycle 2007, 6:2633-2639.
37. Verfaillie A., Imrichova H., Atak Z.K., Dewaele M., Rambow F., Hulselmans G., Christiaens V., Svetlichnyy D., Luciani F., Van den Mooter L., et al. Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat. Commun. 2015, 6:6683.
38. Wang Y., Lonard D.M., Yu Y., Chow D.C., Palzkill T.G., Wang J., Qi R., Matzuk A.J., Song X., Madoux F., et al. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res. 2014, 74:1506-1517.
39. Wu S., Liu Y., Zheng Y., Dong J., Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell 2008, 14:388-398.
40. Wu X., Kodama A., Fuchs E. ACF7 regulates cytoskeletal-focal adhesion dynamics and migration and has ATPase activity. Cell 2008, 135:137-148.
41. Xu J., Wu R.C., O'Malley B.W. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat. Rev. Cancer 2009, 9:615-630.
42. Xu M.Z., Chan S.W., Liu A.M., Wong K.F., Fan S.T., Chen J., Poon R.T., Zender L., Lowe S.W., Hong W., Luk J.M. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 2011, 30:1229-1240.
43. Yan J., Yu C.T., Ozen M., Ittmann M., Tsai S.Y., Tsai M.J. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res. 2006, 66:11039-11046.
44. Zanconato F., Forcato M., Battilana G., Azzolin L., Quaranta E., Bodega B., Rosato A., Bicciato S., Cordenonsi M., Piccolo S. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat. Cell Biol. 2015, 17:1218-1227.
45. Zhang H., Liu C.Y., Zha Z.Y., Zhao B., Yao J., Zhao S., Xiong Y., Lei Q.Y., Guan K.L. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biol. Chem. 2009, 284:13355-13362.
46. Zhang J., Ji J.Y., Yu M., Overholtzer M., Smolen G.A., Wang R., Brugge J.S., Dyson N.J., Haber D.A. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nat. Cell Biol. 2009, 11:1444-1450.
47. Zhang T., Inesta-Vaquera F., Niepel M., Zhang J., Ficarro S.B., Machleidt T., Xie T., Marto J.A., Kim N., Sim T., et al. Discovery of potent and selective covalent inhibitors of JNK. Chem. Biol. 2012, 19:140-154.
48. Zhao B., Ye X., Yu J., Li L., Li W., Li S., Yu J., Lin J.D., Wang C.Y., Chinnaiyan A.M., et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008, 22:1962-1971.
49. Zhao B., Li L., Wang L., Wang C.Y., Yu J., Guan K.L. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 2012, 26:54-68.